文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

基于间充质干细胞的药物递送系统的最新进展、挑战及改进。

Current advances and challenges of mesenchymal stem cells-based drug delivery system and their improvements.

机构信息

College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China; Hangzhou Institute of Innovative Medicine, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.

College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China; Dr. Li Dak Sum & Yip Yio Chin Center for Stem Cell and Regenerative Medicine, Zhejiang University, Hangzhou 310058, China.

出版信息

Int J Pharm. 2021 May 1;600:120477. doi: 10.1016/j.ijpharm.2021.120477. Epub 2021 Mar 16.


DOI:10.1016/j.ijpharm.2021.120477
PMID:33737099
Abstract

Mesenchymal stem cells (MSCs) have recently emerged as a promising living carrier for targeted drug delivery. A wealth of literature has shown evidence for great advances in MSCs-based drug delivery system (MSCs-DDS) in the treatment of various diseases. Nevertheless, as this field of study rapidly advances, several challenges associated with this delivery strategy have arisen, mainly due to the inherent limitations of MSCs. To this end, several novel technologies are being developed in parallel to improve the efficiency or safety of this system. In this review, we introduce recent advances and summarize the present challenges of MSCs-DDS. We also highlight some potential technologies to improve MSCs-DDS, including nanotechnology, genome engineering technology, and biomimetic technology. Finally, prospects for application of artificially improved MSCs-DDS are addressed. The technologies summarized in this review provide a general guideline for the improvement of MSCs-DDS.

摘要

间充质干细胞(MSCs)最近作为一种有前途的靶向药物传递的活体载体出现。大量文献表明,MSCs 为基于药物传递系统(MSCs-DDS)在治疗各种疾病方面的进展提供了有力证据。然而,随着该研究领域的快速发展,与该传递策略相关的一些挑战也随之出现,主要是由于 MSCs 的固有局限性。为此,正在开发一些新技术来提高该系统的效率或安全性。在这篇综述中,我们介绍了最近的进展,并总结了 MSCs-DDS 目前面临的挑战。我们还强调了一些提高 MSCs-DDS 的潜在技术,包括纳米技术、基因组工程技术和仿生技术。最后,探讨了人工改进的 MSCs-DDS 的应用前景。本综述中总结的技术为 MSCs-DDS 的改进提供了一般指导。

相似文献

[1]
Current advances and challenges of mesenchymal stem cells-based drug delivery system and their improvements.

Int J Pharm. 2021-5-1

[2]
Enhanced Drug Delivery System Using Mesenchymal Stem Cells and Membrane-Coated Nanoparticles.

Molecules. 2023-2-24

[3]
Mesenchymal stem cells: A living carrier for active tumor-targeted delivery.

Adv Drug Deliv Rev. 2022-6

[4]
Mesenchymal stem cell-based drug delivery strategy: from cells to biomimetic.

J Control Release. 2018-12-13

[5]
Nanotechnology and bioengineering approaches to improve the potency of mesenchymal stem cell as an off-the-shelf versatile tumor delivery vehicle.

Med Res Rev. 2024-7

[6]
Biomimetic drug delivery platforms based on mesenchymal stem cells impregnated with light-responsive submicron sized carriers.

Biomater Sci. 2019-10-4

[7]
Recent Advances in Endocrine, Metabolic and Immune Disorders: Mesenchymal Stem Cells (MSCs) and Engineered Scaffolds.

Endocr Metab Immune Disord Drug Targets. 2018

[8]
[Application of mesenchymal stem cells in antineoplastic drugs delivery for tumor-targeted therapy].

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2018-5-25

[9]
Nano-Engineered Mesenchymal Stem Cells Increase Therapeutic Efficacy of Anticancer Drug Through True Active Tumor Targeting.

Mol Cancer Ther. 2018-3-28

[10]
Mesenchymal stem cells: a potential targeted-delivery vehicle for anti-cancer drug, loaded nanoparticles.

Nanomedicine. 2012-7-5

引用本文的文献

[1]
Stem Cell for Cancer Immunotherapy: Current Approaches and Challenges.

Stem Cell Rev Rep. 2025-10

[2]
Progress of mesenchymal stem cell-derived exosomes in targeted delivery of antitumor drugs.

Cancer Cell Int. 2025-4-29

[3]
Global Advancements in Bioactive Material Manufacturing for Drug Delivery: A Comprehensive Study.

ACS Omega. 2025-1-3

[4]
Exploring the therapeutic potential of different sources of mesenchymal stem cells: a novel approach to combat burn wound infections.

Front Microbiol. 2024-11-29

[5]
Mesenchymal stem cell-delivered paclitaxel nanoparticles exhibit enhanced efficacy against a syngeneic orthotopic mouse model of pancreatic cancer.

Int J Pharm. 2024-12-5

[6]
Applications of Modified Mesenchymal Stem Cells as Targeted Systems against Tumor Cells.

Int J Mol Sci. 2024-7-16

[7]
Precision Nanomedicine with Bio-Inspired Nanosystems: Recent Trends and Challenges in Mesenchymal Stem Cells Membrane-Coated Bioengineered Nanocarriers in Targeted Nanotherapeutics.

J Xenobiot. 2024-6-24

[8]
Current Strategies and Therapeutic Applications of Mesenchymal Stem Cell-Based Drug Delivery.

Pharmaceuticals (Basel). 2024-5-30

[9]
Targeted drug delivery of engineered mesenchymal stem/stromal-cell-derived exosomes in cardiovascular disease: recent trends and future perspectives.

Front Bioeng Biotechnol. 2024-3-15

[10]
Nanoparticles and Mesenchymal Stem Cell (MSC) Therapy for Cancer Treatment: Focus on Nanocarriers and a si-RNA CXCR4 Chemokine Blocker as Strategies for Tumor Eradication In Vitro and In Vivo.

Micromachines (Basel). 2023-11-7

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索